Pranoprofen APIs from Loncom Pharma are known for their exceptional anti-inflammatory and analgesic properties, ideal for formulating medications that treat a variety of conditions, including ocular inflammation and rheumatoid arthritis, while minimizing adverse effects.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
